Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non- inferiority trial (STANDLOW).

Giussani G;Bianchi E;Carlando E;DiFrancesco JC;Tabaee Damavandi P;Pasini F;Pederzoli G;Filipponi S;Gaiani A;Massacesi L;Rosati E;Giovannelli G;Cantisani TA;Cecconi M;Papetti R;Brioschi M;Aruta F;Agostoni EC;Paladin F;Dainese F;Longoni M;Yerma B;Gasparini S;Aguglia U;Ferlazzo E;Cantello R;Strigaro G;Maschio M;Benincasa D;La Neve A;Falcicchio G;Giordano A;Buttarelli L;Enia G;Leone M;Ferrarese C;Beghi E;Beretta S.

2025-01-01